BLM induces pulmonary inflammation and PF within a short time, while BLM administered intratracheally up-regulates fibrotic factor levels, like IL-1β, IL-6, TNF-α, and TGF-β, etc. [21]. This evidence concerns the gene IL1B and inflammatory response.